Takeda Pharmaceutical (TAK) P/B ratio

There is no P/B ratio history on record here for Takeda Pharmaceutical (TAK). Its statements are in JPY and its shares trade in USD, so figures at past share prices are not worked out. Figures as of 18 Nov 2026, 08:25 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/B ratio needs at least 3 fiscal years; none is on record here for Takeda Pharmaceutical. Nothing is estimated to fill the gap. What is on record is in the table below.

Takeda Pharmaceutical P/B ratio, year by year

Takeda Pharmaceutical (TAK) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedBook value per share
2026——¥2,317.67
2025——¥2,160.03
2024——¥2,301.17
2023——¥2,023.77

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Takeda Pharmaceutical and comparable companies
CompanyP/B ratio
Cencora COR44.4×
Boston Scientific BSX2.6×
argenx ARGX8.1×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical P/B ratio: questions and answers

How is Takeda Pharmaceutical's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/pb-ratio

Underlying data: Yahoo Finance.